is in office
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ABBV's Mavyret weekly NRx market share of the HCV market is at 49% (from 50% the prior week) for the week ending 6/14.
ABBV's Mavyret weekly NRx market share of the HCV market is at 51% (from 49% the prior week) for the week ending 5/31.
ABBV's Mavyret weekly NRx market share of the HCV market is at 49% (from 51% the prior week) for the week ending 5/24.
ABBV's Mavyret weekly NRx market share of the HCV market is at 51% (from 50% the prior week) for the week ending 5/17.
ABBV's Mavyret weekly NRx market share of the HCV market is at 50% (from 48% the prior week) for the week ending 5/10.
ABBV's Mavyret weekly NRx market share of the HCV market is at 48% (from 52% the prior week) for the week ending 5/3.
ABBV's Mavyret weekly NRx market share of the HCV market is at 52% (from 54% the prior week) for the week ending 4/26.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 52% the prior week) for the week ending 4/19.
ABBV's Mavyret weekly NRx market share of the HCV market is at 52% (from 53% the prior week) for the week ending 4/5.
ABBV's Mavyret weekly NRx market share of the HCV market is at 53% (from 54% the prior week) for the week ending 3/29.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 54% the prior week) for the week ending 3/22.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 56% the prior week) for the week ending 3/15.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 55% the prior week) for the week ending 3/1.
ABBV's Mavyret weekly NRx market share of the HCV market is at 55% (from 53% the prior week) for the week ending 2/22.
ABBV's Mavyret weekly NRx market share of the HCV market is at 53% (from 56% the prior week) for the week ending 2/15.
ABBV's Mavyret weekly NRx market share of the HCV market is at 59% (from 56% the prior week) for the week ending 2/1.
ABBV's Mavyret weekly NRx market share of the HCV market is at 56% (from 56% the prior week) for the week ending 1/25.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 51% the prior week) for the week ending 1/11.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 53% the prior week) for the week ending 12/28 (prior week was Christmas)
ABBV's Mavyret weekly NRx market share of the HCV market is at 55% (from 53% the prior week) for the week ending 11/30.
ABBV's Mavyret weekly NRx market share of the HCV market is at 53% (from 51% the prior week) for the week ending 11/23.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 53% the prior week) for the week ending 11/9
ABBV's Mavyret weekly NRx market share of the HCV market is at 53% (flat to the prior week) for the week ending 11/2.
ABBV's Mavyret weekly NRx market share of the HCV market is at 53% (from 54% the prior week) for the week ending 10/26.
ABBV's Mavyret weekly NRx market share of the HCV market is at 54% (from 52% the prior week) for the week ending 10/19.
ABBV's Mavyret weekly NRx market share of the HCV market is at 52% (from 53% the prior week) for the week ending 10/12.
ABBV's Mavyret weekly NRx market share of the HCV market is at 52% (from 50% prior week) for the week ending 9/7.
ABBV's Mavyret weekly NRx market share of the HCV market is at 50% (from 52% the previous week) for the week ending 8/31.
ABBV's Mavyret weekly NRx market share of the HCV market is at 52% (from 49% the previous week) for the week ending 8/24.
ABBV's Mavyret weekly NRx market share of the HCV market is at 49% (from 52% the prior week) for the week ending 8/17.
ABBV's Mavyret weekly NRx market share of the HCV market is at 48% (from 49% the prior week) for the week ending 7/6.
ABBV's Mavyret weekly NRx market share of the HCV market is at 49% (from 49% the prior week) for the week ending 6/29.
ABBV's Mavyret weekly NRx market share of the HCV market is at 49% (from 48% prior week) for the week ending 6/22
ABBV's Mavyret weekly NRx market share of the HCV market is at 48% (from 49% prior week) for the week ending 6/15.
ABBV's Mavyret weekly NRx market share of the HCV market is at 49% (from 47% the previous week) for the week ending 6/8.
HCV Weekly NRx Market Share for Week Ending 6/1 (including Holiday on 5/28) Mavyret @ 47%
ABBV's Mavyret weekly NRx market share of the HCV market is 47% (from 47% the prior week) for the week ending 5/25.
ABBV's Mavyret weekly NRx market share of the HCV market is at 45% (from 46% the previous week) for the week ending 5/4.
ABBV's Mavyret weekly NRx market share of the HCV market is at 46% (from 48% the previous week) for the week ending 4/27.
ABBV's Mavyret weekly NRx market share of the HCV market is at 48% (vs. 44% the prior week) for the week ending 4/20.